Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 4Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 2Prostatic Neoplasms 1Postoperative Nausea and Vomiting 1Pain, Postoperative 1Neoplasms 1Lung Neoplasms 1Colonic Neoplasms 1Agnosia 1

Interventions

Dexamethasone 33Palonosetron 27Aprepitant 24Ondansetron 23Granisetron 14Calcium Dobesilate 8Therapeutics 7Olanzapine 6fosaprepitant 5dexamethasone acetate 5netupitant, palosentron drug combination 4casopitant 4Doxorubicin 4Cyclophosphamide 4Acupressure 4netupitant 3dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Radiotherapy 3Metoclopramide 3Dronabinol 3Analgesia 3ramosetron 2ginger extract 2dexamethasone 21-phosphate 2Vincristine 2Tablets 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Vomiting × ramosetron × Clear all
NCT02532634 2018-05-11

RAPA

Kangdong Sacred Heart Hospital

Phase 4 Completed
292 enrolled

Neoplasms, Vomiting

NCT00971399 2011-02-28

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Seoul National University Hospital

Phase 3 Completed
172 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡